News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) (JOBS) in $25 Million-Plus Deal with Harvard Stem Cell Institute



7/24/2008 7:13:45 AM

LONDON, July 24 (Reuters) - GlaxoSmithKline Plc, the world's second biggest drugmaker, has signed a $25 million-plus deal with the Harvard Stem Cell Institute to harness stem cell technology for the development of new medicines.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES